Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.
Primary care consulting for GP practices & PCNs across England. Get in touch →
MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) Drug alert number: EL(26)A/39 Date issued: 23 September 2026 B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg [...]
The post MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) appeared first on Community Pharmacy England.
Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.